Navigation Links
Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference
Date:2/24/2009

Online-Only Event Brings Together Leading Cardiovascular Experts

LAS VEGAS, Feb. 24 /PRNewswire/ -- Noninvasive Medical Technologies, Inc. (NMT), an award-winning company engaged in pioneering highly advanced remote patient monitoring solutions, today announced that the Company will be showcasing its compelling suite of patented noninvasive medical assessment and communications products at CardioCareLive, an online-only conference to be held on March 3-4, 2009.

CardioCareLive is a cardiovascular medical conference dedicated to the management of patients with multiple cardiovascular risk factors. This online medical conference is designed to bring together cardiologists, primary care physicians, endocrinologists, nurses, diabetes educators, physician assistants, pharmacists, and other healthcare professionals with experts in the field of cardiometabolic risk factors in a unique, virtual environment.

Participating as a virtual exhibitor, NMT will feature its novel remote patient monitoring solutions designed to assist clinicians in the management of chronic health conditions. Specific products being showcased are:

  • the IQ2(TM), an impedance cardiograph, or ICG, device that uses thoracic electrical bioimpedance, or TEB, to noninvasively monitor hemodynamics (the blood flow, cardiac output, cardiac index, stroke volume, heart rate and other aspects of left ventricular performance). This novel solution provides medical professionals with noninvasive access to objective patient data in order to effectively assess, diagnose and treat heart failure, high blood pressure, shortness of breath, trauma, patients with a pacemaker, and End Stage Renal Disease patients; and
  • the ZOE(R) fluid status monitor, which is practical for use in the home as well as in a physician's office, measures thoracic base impedence ("Zo"), providing clinicians with a quick and easy method of determining whether patients are experiencing fluid congestion or dehydration. By quantifying fluid volume status, clinicians can optimize medical regimens and hydration critical in the management of patients suffering from Heart Failure, Hypertension and ESRD, or other individuals at risk for severe or recurrent dehydration. Currently, there is no other device on the market that noninvasively provides a clinician with only an objective assessment of a patient's fluid status.

CardioCareLive will feature noted experts such as Roger Blumenthal, MD, Johns Hopkins School of Medicine; Robert Eckel, MD, University of Colorado Denver and former President, American Heart Association; Clyde Yancy, MD, Baylor Heart & Vascular Institute and incoming President, American Heart Association, and other preeminent leaders in the care and treatment of cardiometabolic diseases. To preview a complete list of scheduled speakers, exhibitors and conference details, or to pre-register for the event (no cost), visit www.CardioCareLive.com.

About CardioCareLive

CardioCareLive is an online-only event dedicated to the management of patients with multiple cardiovascular risk factors. CardioCareLive also offers Continuing Medical Education (CME) produced under the auspices of the Johns Hopkins Office of Continuing Medical Education. CardioCareLive delivers all the benefits of a physical medical conference, with live keynote presentations, lectures, peer networking and an exhibit floor, from the convenience of a computer and is produced by PlatformQ, whose mission is to connect people, companies, organizations and associations worldwide to meet, interact and learn from leading experts and thought leaders through proven interactive tools at online events.

CardioCareLive and PlatformQ are trademarks of PlatformQ, LLC. All other trademarks or service marks are property of their respective owners.

About Noninvasive Medical Technologies, Inc.

Headquartered in Las Vegas, Nevada, Noninvasive Medical Technologies, Inc. (NMT) is an award-winning company engaged in pioneering highly advanced remote, noninvasive and non-contact patient monitoring solutions for use in military, federal and state government, general healthcare, emergency/disaster response and consumer applications, among many more. NMT's mission is to save lives by continually advancing the standard for noninvasive patient monitoring across the care continuum, while maximizing clinical, medical and financial outcomes, and promoting scientific innovation. To learn more, please visit www.nmtinc.org.

                    FOR MORE INFORMATION, PLEASE CONTACT:
                    Noninvasive Medical Technologies, Inc.
        Laura Dolajak, 888-466-8552 or via email at ldolajak@nmtinc.org
                                     OR
              Elite Financial Communication Group/Elite Media Group
              Dodi Handy, 407-585-1080 or via email at NMT@efcg.net


'/>"/>
SOURCE Noninvasive Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Noninvasive tests for cirrhosis may help to avoid liver biopsy
2. Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume
3. Noninvasive ways to assess liver disease
4. Noninvasive Procedures Show Promise for Esophageal Bleeding
5. Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin
6. PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer
7. U.S. Air Force Awards Noninvasive Medical Technologies $2.4 Million Contract
8. Noninvasive screening test may detect narrowing in intracranial stents
9. MSU engineering team designs innovative medical device
10. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
11. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically ... announced three leadership team developments today:   ... ... Tom ... Veteran medical device executive Josh Stopek , PhD, who ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology: